Scancell Holdings plc reported earnings results for the half year ended October 31, 2023. For the half year, the company reported net loss was GBP 2.55 million compared to GBP 4.96 million a year ago. Basic loss per share from continuing operations was GBP 0.0031 compared to GBP 0.0061 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.875 GBX | +1.80% | +7.92% | -5.95% |
03-26 | Scancell doses first patient in melanoma-focused trials | AN |
03-22 | Seneca Growth Capital announces tepid 2023 results | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.95% | 101M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SCLP Stock
- News Scancell Holdings plc
- Scancell Holdings plc Reports Earnings Results for the Half Year Ended October 31, 2023